Priya S Chockalingam | Vice President, Head of Clinical Bioanalytics & Translational Sciences
Beam Therapeutics

Priya has a PhD in Biochemistry and currently VP and Head of Clinical Bioanalytics & Translational Sciences at Beam Therapeutics. She manages a function within clinical that works across R&D and holds responsibility for bioanalytical, biomarker and forward & reverse translational strategies followed by implementation for a broad pipeline of clinical programs in hematology, immunology, oncology, and rare genetic diseases that leverage base editing technologies, auto/allo cell therapies and novel delivery modalities like LNP. Prior to Beam, she had worked for 20+ years on Translational Medicine, Bioanalytics, Biomarkers & Diagnostics at Wyeth, Pfizer, Takeda (L-Shire) and Biogen.